CPI Card Group Inc.
CPI Card Group Inc. Q1 FY2025 earnings call
May 11, 2025 · fiscal period ended 2025-03
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2025-05-11
Management highlights
- Announced acquisition of Arroweye Solutions, a provider of digitally-driven on-demand payment card solutions for the US market, which fits in with strategies to gain share and diversify business. - First quarter sales performance led by debit, credit, and prepaid, both up 10%. - Adjusted EBITDA declined 8% in the first quarter due to mix issues and production costs. - Affirmed 2025 organic outlook for mid-to-high single digit growth in net sales and adjusted EBITDA. - Focus on driving sales growth while balancing long-term investments and managing spending to improve margins. - Arroweye's technology-driven platform eliminates inventory needs, allows hyper-personalization, and has low-double-digit adjusted EBITDA margins currently, with potential for margins to move closer to CPI levels over time.
Segment performance
In the first quarter, both debit and credit and prepaid segments increased 10% in sales. Debit and credit growth was led by contactless cards including eco-focused cards, with personalization services declining. Prepaid growth was driven by higher value fraud prevention packaging solutions in healthcare. Income from operations for the debit and credit segment decreased 5% in the first quarter due to lower gross margins and increased operating expenses. The prepaid debit segment income from operations decreased 9% as benefits from sales growth were offset by lower gross margins impacted by sales mix.
Guidance
- Affirmed 2025 organic net sales and adjusted EBITDA outlook for mid-to-high single digit growth, with Arroweye acquisition's contribution not included. - Expected free cash flow to be lower in 2025 due to Arroweye integration, inventory purchases, and tariff impacts. - Net leverage ratio impacted by acquisition, expected to improve in 2026. - Earnings per share from Arroweye expected to be dilutive in 2025-2026, then accretive in 2027. - Anticipate utilizing around $5 million of Arroweye’s net operating loss tax benefits in coming years.
Risks
- Uncertainty in the US economic outlook which could affect issuances and customer purchases. - Potential additional tariff issues impacting costs. - Mix impacts and production costs affecting gross margins. - Transition and integration costs related to the Arroweye acquisition impacting financial results in the short term.
Q&A highlights
Q: Pete Heckmann asked about Arroweye's customer base and margin expectations.
A: John Lowe explained Arroweye serves nimble card programs like fintechs wanting to test small, nimble card programs, with low-double-digit adjusted EBITDA margins currently, and Jeff Hochstadt added that CPI's purchasing power will help bring Arroweye's margins closer to CPI levels over time.
Q: Jacob Stephan asked about balance sheet moves for the acquisition.
A: Jeff Hochstadt said they ended the quarter with over $30 million in cash and drew about $35 million from the revolver to finance the Arroweye acquisition.
Q: Craig Irwin asked about pricing, Indiana startup costs.
A: Jeff Hochstadt discussed margin pressures due to sales mix and production costs, SG&A actions to offset margin decline, and John Lowe mentioned Indiana transition costs tapering over time as the new facility comes online while still running both facilities for a period to not lose customer steps.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
May 11, 2025Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.